Social Media Ideas for Clinical Trials

HHS launches initiatives to make clinical trials faster

HHS launched a multi-component effort intended to improve the speed and efficiency with which clinical trials are conducted.The series of initiatives is designed to eliminate dupli...

HHS kicks off new programs to speed clinical trials as Chinese competition looms

The department is offering funding to teams with innovative proposals as it considers ending the traditional phased clinical trial system.

<![CDATA[EMA Steps Up Push for Greater Clinical Trial Transparency]]>

The Trials Were Always There — Patients Just Couldn’t Find Them

This structural problem calls for a structural solution, requiring no new science, regulation, or data.  The post The Trials Were Always There — Patients Just Couldn’t Find Them ap...

Innovative Trials launches global education programme as survey exposes major misconceptions about clinical trials

New research finds almost three quarters of UK adults believe they understand clinical trials, yet many misunderstand how they work. Now, Innovative Trials - a leading clinical tri...

<![CDATA[Accelerating patient recruitment: Connecting the right patients to the right trial]]>

<![CDATA[How AI is Being Used to Prevent Clinical Trial Mismatches]]>

Building Clinical Trial Matchmaker: Evidence-First Agentic RAG

How I combined grounded retrieval, structured screening drafts, and independent model review in an inspectable clinical-trial demo.Continue reading on Medium »

Clinical trial navigation is a clinical access problem

Clinical trial enrollment in rare cancers remains stubbornly low. In T-cell lymphomas, a heterogeneous group of over a dozen distinct subtypes affecting roughly 9,000 new patients...

<![CDATA[6 Ways Lab Data Can Improve Clinical Trials]]>

New therapy moves closer to Phase 2 testing in progressive MS

Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in peop...

When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients

Discover Andy Brown's long and arduous journey battling a type of non-Hodgkin lymphoma and how a clinical trial altered his treatment outlook. The post When every treatment counts:...

<![CDATA[BioNTech Terminates Phase II Clinical Trial for Cevumeran ]]>

<![CDATA[Moving Beyond the Sample Size Guess: Lessons from 60 Million Clinical Trial Simulations]]>

<![CDATA[Is Your Clinical Trial Enrolling the Right Patients? Q&A with Jen Lamppa]]>

<![CDATA[Laboratory Advantage: End-to-End Solutions for Increased Complexity in Clinical Trials]]>

<![CDATA[5 Essential Capabilities for Decentralized Clinical Trials]]>

FDA launches pilot program to speed up early US drug research

First teased in June and formally announced Tuesday as part of “Operation Trialblazer,” the program will partner drugmakers with research institutions to more quickly bring medicin...

Clinical trials for Alzheimer’s treatment face global shortage of participants

The shortage of trial participants risks slowing progress in dementia therapies, Alzheimer's Disease International warns.

Dallas researchers seeking patients for breast cancer treatment clinical trial

A clinical trial going on now at UT Southwestern Medical Center in Dallas could lead to a new treatment option for some breast cancer patients. And more women are needed as the...

A trial to compare HSCT and alemtuzumab is needed…Are we dreaming?

Is there advantage of stem therapy over standard immunosuppressive treatment? Let’s look at the data and the answer is probably yes….but then we get the punchline “Well-designed ra...

The human side of clinical trials that no data captures

There are patients you remember for their diagnosis. And then there are patients you remember for who they were. He was the second kind. Years ago, during my time in oncology clini...

EU health ministers discuss medicines, clinical trials

An informal meeting of EU health ministers in Dublin is discussing boosting manufacturing capacity for medicines and growing the number of clinical trials in Europe.